Prismatic Image Relocation in Macular Disease: Effects on Visual Function and the Preferred Retinal Locus-A Systematic Review and Meta-Analysis
In brief
Two trials leave prism aids' effect on distance vision uncertain
A review of 11 studies found too little reliable evidence to establish that prisms improve distance visual acuity in people with central vision loss; the two comparable randomized trials gave a highly uncertain, mixed result. Observational studies often reported functional gains, but bias and sparse data leave open whether selected patients benefit in structured low-vision rehabilitation.
- Journal
- Journal of clinical medicine (Q1)
- Published
- 26 October 2026
- Study design
- Systematic review / meta-analysis of RCTs
- Evidence level
- Level 1, High (CEBM 1a)
- Authors
- Francisco Javier Povedano-Montero, Rut González-Jiménez, Ricardo Bernárdez-Vilaboa, Sofia Bernardez-Sánchez, Juan E Cedrún-Sánchez
- PMID
- 43030465
- DOI
- 10.3390/jcm15218322
Why clinicians should know about it
- Picked for Ophthalmology (top studies of the week, 15 November 2026): Evaluates visual rehabilitation for central vision loss from macular disease
Abstract
Purpose: To evaluate the effectiveness of prismatic image relocation for visual rehabilitation in patients with macular disease and central vision loss, focusing on visual acuity, reading-related outcomes, preferred retinal locus (PRL) behaviour, fixation, and functional outcomes. Methods: A systematic review and meta-analysis was conducted according to PRISMA 2020 and prospectively registered in PROSPERO (CRD420261500738). Scopus, Web of Science Core Collection, PubMed/MEDLINE, and CENTRAL were searched from inception, with searches conducted between 2 and 15 September 2026. Randomized, non-randomized comparative, pre-post, and case-series studies evaluating prism-based image relocation were eligible. Risk of bias was assessed using RoB 2, ROBINS-I, or the appropriate Joanna Briggs Institute tools. Random-effects meta-analysis was performed when studies were sufficiently comparable. Results: Eleven studies met the inclusion criteria. Two randomized controlled trials provided comparable data for an exploratory meta-analysis of distance visual acuity. The pooled point estimate favoured prism correction (MD, -0.218 logMAR), but the Hartung-Knapp-adjusted 95% confidence interval was extremely wide (-2.188 to 1.753) and included the null effect, with substantial heterogeneity (I2 = 94.5%). The certainty of evidence for the primary outcome was rated as very low. Sensitivity analyses did not materially strengthen the evidence. Observational studies frequently reported favourable visual or functional outcomes, but several were affected by important risks of selection bias, confounding, or absence of appropriate control groups. Evidence concerning PRL relocation and fixation behaviour was sparse, heterogeneous, predominantly non-randomized, and unsuitable for quantitative synthesis. Conclusions: Current evidence is insufficient to establish the routine efficacy of prismatic image relocation for improving distance visual acuity in patients with macular disease and central vision loss. Prism correction may nevertheless provide visual or functional benefit in selected individuals and may be considered as an individualized component of structured low-vision rehabilitation.
Abstract as published, via PubMed.
For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.